Skip to main content

Jason Smith

Equibles does not estimate personal net worth.

Get an email with a short summary when UroGen Pharma Ltd. publishes a filing, an earnings call transcript or a press release.

Get URGN alerts

About Jason Smith

Jason Smith is recorded as General Counsel at UroGen Pharma Ltd. (URGN). The newest filing on record that lists Jason Smith as General Counsel at UroGen Pharma Ltd. (URGN) is dated April 30, 2026. The proxy statement of UroGen Pharma Ltd. reports total compensation of $1,198,618 for Jason Smith in fiscal 2025, including a base salary of $492,011. Disclosed compensation is on record for 6 fiscal years. UroGen Pharma Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at UroGen Pharma Ltd. includes Elizabeth Barrett (CEO and Board Member), Arie Belldegrun (Chairman and Board Member), Chris Degnan (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at UroGen Pharma Ltd.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 UroGen Pharma Ltd. (URGN) $492,011 $1,198,618
2024 UroGen Pharma Ltd. (URGN) $475,003 $1,275,464
2023 UroGen Pharma Ltd. (URGN) $456,733 $1,508,179
2022 UroGen Pharma Ltd. (URGN) $440,019 $926,121
2021 UroGen Pharma Ltd. (URGN) $429,260 $1,058,671
2020 UroGen Pharma Ltd. (URGN) $126,930 $1,615,273

Recent activity

No call appearances or filed executive changes recorded yet.